Aspire Biopharma Holdings, Inc. (ASBP) Gross Profit (2025 - 2026)
Aspire Biopharma Holdings' Gross Profit came in at -$30,086 for Q2 2026.
Powered by 
Analysis
Aspire Biopharma Holdings, Inc. (ASBP) Gross Profit (2025 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aspire Biopharma Holdings reported Gross Profit of -$24,452; for FY2025, it came in at -$116.00.
- Business Quant data shows ASBP's Gross Profit at $5,750 (Q1 2026), -$1,000 (Q4 2025) and $884.00 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -30,086.00 |
| Mar 31, 2026 | 5,750.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 884.00 |
API Access
Aspire Biopharma Holdings, Inc. Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ASBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ASBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ASBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();